50000 Illegal Retatrutide Doses Seized!

The latest GLP-1 news includes major developments involving Eli Lilly's Zepbound, Mounjaro and retatrutide, Novo Nordisk's Wegovy and Ozempic, Lilly's Foundayo, Viking Therapeutics' VK2735, and Amgen's MariTide. In this week's The Downsized News, Christopher and Laraine Durham cover the seizure of 50,000 illegal doses of experimental retatrutide in Britain, new research into whether patients could maintain their weight loss with monthly GLP-1 injections or pills, and a Mayo Clinic study examining whether menopause hormone replacement therapy (HRT) improves weight loss with semaglutide (Ozempic and Wegovy) or tirzepatide (Mounjaro and Zepbound). They also break down the latest prescription numbers in the growing GLP-1 pill race between Novo Nordisk's oral Wegovy and Eli Lilly's Foundayo, along with Amgen's new Phase 3 MariTide clinical trials, including opportunities for patients currently taking Wegovy or Zepbound to participate in research. New results from Eli Lilly explore whether combining Zepbound with the psoriasis medication Taltz can improve outcomes for patients living with obesity and plaque psoriasis. Plus, could medications like Ozempic, Wegovy, Mounjaro, and Zepbound be associated with fingernail problems? Can one person's GLP-1 treatment help other family members lose weight? And what do the World Health Organization's new childhood obesity guidelines mean for younger patients who may need treatment? Christopher also previews his new 10-part EASD 2026 research series, examining the latest obesity science, including Eli Lilly's retatrutide and experimental amylin treatments such as eloralintide and combinations with tirzepatide. Christopher and Laraine have been taking tirzepatide since September 2023 and have lost more than 150 pounds combined. Each week, they bring their experience as patients to the latest GLP-1 news, obesity research, clinical trials, medication access, and developments affecting people treating the chronic disease of obesity. The episode also includes details about upcoming Downsized LIVE events in New York City and Chicago, along with Downsized at Sea 2027. +++++++++++++++++++++++++++++++++++++++ Start your weight loss journey today! We use Mochi Health: https://app.joinmochi.com/eligibility... Use Laraine’s code for $40 off: QIYGO8. SHOP OUR AMAZON STORE: https://a.co/d/0gGe1MYq BOOK THE DOWNSIZED AT SEA CRUISE 2027: https://thedownsized.org/downsized-at... GET YOUR DOWNSIZED LIVE! ON TOUR TICKETS: https://thedownsized.org/meet-ups/ DOWNSIZED WEBSITE: https://thedownsized.org/ JOIN CLUB DOWNSIZED: https://www.youtube.com/@thedownsized... FOR SPONSORSHIPS, BRAND DEALS & COLLABS: https://thedownsized.org/contact/ +++++++++++++++++++++++++++++++++++++++ 00:00 News 00:26 The Downsized News 01:14 Retatrutide: 50,000 Illegal Doses Seized 05:30 Viking VK2735: Monthly GLP-1 Shots for Maintenance? 08:36 Menopause and GLP-1s: Does HRT Boost Weight Loss? 11:54 Wegovy Pill vs. Foundayo: Who's Winning? 13:58 Amgen MariTide: New Phase 3 Trials 17:26 Zepbound and Psoriasis: New Study Results 20:08 GLP-1 Side Effects: Fingernail Problems? 22:40 Can GLP-1s Help Your Family Lose Weight? 24:41 GLP-1s for Kids: New WHO Obesity Guidelines 28:27 EASD 2026: Retatrutide and Amylin Research 29:06 Downsized LIVE Tour 29:38 Downsized at Sea Cruise 2027